4th Annual CIRM Alpha Stem Cell Clinics Network Symposium

Event date: 
Apr 18, 2019
Event type: 
CIRM-Funded Conference

The theme of this year's symposium is Mending Stem Cells: the Past, Present & Future of Regenerative Medicine.

The symposium aims to address advancements and accomplishments of the ASCC Network in addition to developments and applications in the field of stem cell-based therapeutics. The Alpha Stem Cell Clinics Network was established with a main goal in mind: to accelerate the development and delivery of high-quality stem cell clinical trials to patients. This meeting will bring together clinical investigators, scientists, patients, patient advocates, and the public in a thoughtful discussion on how novel stem cell therapies are now a reality.

This meeting is free and open to the public. Here is the agenda.

4TH ANNUAL CIRM ALPHA STEM CELL CLINICS NETWORK SYMPOSIUM

 

MENDING STEM CELLS:  THE PAST, PRESENT & FUTURE OF REGENERATIVE MEDICINE

LOCATION:             UCSF Mission Bay Conference Center, 1675 Owens Street, San Francisco

DATE:                        Thursday, April 18, 2019

TIME:                        8:30 am – 4:30 pm

REGISTRATION & LIGHT BREAKFAST (8:30 AM – 9:00 AM)

 

9:00 AM – 9:10 AM                 UCSF ASCC Welcome Arnold Kriegstein, PhD, UCSF Broad Center for Regenerative Medicine

9:10 AM – 9:15 AM                 Summary of Our Success & Vision for the Future Maria Millan, MD, CIRM


SESSION 1 – Key Note Speakers  (Moderator – Mark Walters, MD from UCSF)

9:15 AM – 9:35 AM                 Topic – Origins of Gene Editing and its use in the clinic     Fyodor Urnov, PhD - UCB                                                  

9:35 AM – 9:55 AM                 Topic – Current indications of Gene Therapy for hereditary diseases  Don Kohn, MD - UCLA

9:55 AM – 10:15 AM               Topic – The future possibilities of CRISPR Therapy in the clinic  Alex Marson, MD, PhD – UCSF

BREAK (10:30 – 10:45 AM)


SESSION 2 –Sickle Cell Cures Initiative Mending Blood Cells for a Cure  (Moderator – Mehrdad Abedi, MD, from UC Davis)

10:45 AM – 11:10 AM            Topic:  American Society of Hematology & Sickle Cell Initiative Alexis Thompson, MD, MPH – Northwestern University (past President of American Soc. of Hematology)

11:10 AM – 11:30 AM            Topic:  Partnering with the community to develop cures  Marsha Treadwell, PhD -  UCSF BCHO

11:30 AM – 11:50 PM             Topic:  Caring for patients & their families while in gene therapy trials Marci Moriarity, RN – UCSF BCHO

11:50 PM – 12:10  PM            Topic:  Personal Story – curative treatment for Sickle Cell Disease  Cierra Danielle Jackson -   Patient Advocate -City of Hope

LUNCH (12:30 – 1:15 PM)


SESSION 3 – Engineering Cells to Fight Disease  (Catriona Jamison, MD, from UCSD)

1:15 PM – 1:35 PM                  Topic:  Treating Cancer with  the immune system Elizabeth Budde, MD, PhD -  City of Hope

1:35 PM – 1:55 PM                  Topic:  Caring for patients & their families while in gene therapy trials Stephanie Jackson, MSN, RN, AOCNS, BMTCN - UCLA

1.55 PM - 2.15 PM.                  Topic: Personal Story - treatment for a hereditary kidney disorder - Cystinosis.  Stephanie Cherqui, PhD- UCSD and Shannon Keizer - Patient Advocate

                                                                                                                                                                              BREAK (2:30 – 2:45 PM)


SESSION 4 -   Finding the Right Treatment  (John A. Zaia, MD, City of Hope)

2.45 PM - 3.00 PM.                   Access to Treatments in California and Right to Try. Daniela Bota, MD - UCI

3:00 PM – 3:20 PM                  Regulation and the Office of Cell Therapy and Gene Therapies Expedited Reviews   Ke Liu, MD, Branch Chief -  Food & Drug Administration, CBER

3.20 PM - 3.50 PM                  NIH Initiative and Curative Therapies for SCD. Ed Benz, MD - Dana Farber Cancer Institute


CLOSING REMARKS

4:00 PM – 4:15 PM                  Closing Remarks -  Mark Walters, MD, UCSF and Geoff Lomax, PhD, CIRM